Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CNS 2a”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01957774
What this trial is testing

THR-18's Pharmacokinetics and Pharmacodynamics in Subjects With Acute Ischemic Stroke Treated With tPA

Who this might be right for
Stroke, Acute
D-Pharm Ltd. 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT07741526
What this trial is testing

Safety, Tolerability and Biomarker-based Efficacy of NPI-001 (AT-001) in Subjects With MCI or Alzheimer's Disease (AD)

Who this might be right for
Alzheimer´s Disease
Arctic Therapeutics 33
Testing effectiveness (Phase 2)UnknownNCT04734379
What this trial is testing

Rho Kinase (ROCK) Inhibitor in Tauopathies - 1

Who this might be right for
Progressive Supranuclear PalsyCorticobasal Syndrome
Woolsey Pharmaceuticals 15
Testing effectiveness (Phase 2)Study completedNCT02868580
What this trial is testing

Safety and Tolerability of Antiretroviral (Triumeq) in Patients With Amyotrophic Lateral Sclerosis (ALS).

Who this might be right for
Amyotrophic Lateral Sclerosis
Neuroscience Trials Australia 43
Testing effectiveness (Phase 2)Study completedNCT06815965
What this trial is testing

A Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies

Who this might be right for
Dementia With Lewy Bodies (DLB)
EIP Pharma Inc 26
Testing effectiveness (Phase 2)Study completedNCT03239691
What this trial is testing

Evaluate the Effect of ACT-709478 in Photosensitive Epilepsy Patients

Who this might be right for
Photosensitive Epilepsy
Idorsia Pharmaceuticals Ltd. 5
Testing effectiveness (Phase 2)Ended earlyNCT00960531
What this trial is testing

A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Pfizer 160
Not applicableUnknownNCT06445582
What this trial is testing

SV2A-PET/CT and PET/MRI Combined Clinical Criteria Score in the Diagnosis of Early Cognitive Alteration

Who this might be right for
Alzheimer Disease
Anhui Provincial Hospital 80
Testing effectiveness (Phase 2)UnknownNCT05234762
What this trial is testing

Efficacy, Safety, and Pharmacokinetics of ES-481 in Adult Patients With Essential Tremors

Who this might be right for
Tremor, Essential
ES Therapeutics Australia Pty Ltd 24
Testing effectiveness (Phase 2)Study completedNCT05358717
What this trial is testing

Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)

Who this might be right for
Huntington Disease
Novartis Pharmaceuticals 159
Testing effectiveness (Phase 2)Looking for participantsNCT07093333
What this trial is testing

A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease

Who this might be right for
Anti-N-methyl-D-aspartate Receptor (NMDAR) Encephalitis (ANRE)Anti-N-methyl-D-aspartate Receptor (NMDAR) Antibody-associated Psychiatric DiseaseAutoimmune Encephalitis
Arialys Australia Pty Ltd 30
Testing effectiveness (Phase 2)Looking for participantsNCT06488313
What this trial is testing

Evaluate the Pharmacodynamics and Safety of ARCT-810 in Participants With OTCD

Who this might be right for
OTC DeficiencyOrnithine Transcarbamylase DeficiencyOTCD
Arcturus Therapeutics, Inc. 9
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Testing effectiveness (Phase 2)Study completedNCT01962363
What this trial is testing

EPI-743 in Friedreich's Ataxia Point Mutations

Who this might be right for
Friedreich's Ataxia
University of South Florida 4
Testing effectiveness (Phase 2)Study completedNCT05176093
What this trial is testing

A 6-Month Extension Study to Assess the Long-Term Safety of Engensis in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Helixmith Co., Ltd. 8
Testing effectiveness (Phase 2)Study completedNCT05104463
What this trial is testing

CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentDementia
CuraSen Therapeutics, Inc. 64
Testing effectiveness (Phase 2)Active Not RecruitingNCT06602193
What this trial is testing

Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)

Who this might be right for
Parkinson Disease
Denali Therapeutics Inc. 50
Testing effectiveness (Phase 2)WithdrawnNCT03474263
What this trial is testing

IC14 for Rapidly Progressive Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Implicit Bioscience
Testing effectiveness (Phase 2)UnknownNCT04253132
What this trial is testing

Evaluation of Tolfenamic Acid in Individuals With PSP at 12-Weeks

Who this might be right for
Progressive Supranuclear Palsy
NeuroTau, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT04569435
What this trial is testing

Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Annexon, Inc. 17
Next Page